Brian Armstrong Investments: Public Portfolio Guide
Brian Nichols is the co-founder of Angel Squad, a community where you’ll learn how to angel invest and get a chance to invest as little as $1k into Hustle Fund’s top performing early-stage startups.
Looking up Brian Armstrong's investments gets confusing fast. Personal angel checks sit beside companies he co-founded and a corporate venture portfolio managed by Coinbase. Those are three different relationships. Separating them shows which investments the public record attributes to Armstrong, which companies he helped build, and where the available data stops.
Brian Armstrong's publicly disclosed angel investments
The clearest free snapshot comes from PitchBook's investor profile. Its current preview classifies Armstrong as an angel investor and reports 20 investments, 13 active portfolio holdings, and five exits. A CB Insights profile reports nine investments.
That difference is normal for private-company data. Rounds can remain private, announcements may omit some participants, and databases use different sourcing and classification rules. Neither count should be treated as a complete statement of Armstrong's current holdings.
We count a deal as personal only when the public record names Armstrong as the individual investor. Founder roles and Coinbase Ventures activity stay in separate buckets.
The following personal investments are visible in PitchBook's public preview:
- Special: A seed investment dated June 2026. PitchBook places the company in its holding-companies category.
- NavigateAI: A May 2026 seed investment in software for construction and field workers. NavigateAI's company announcement says it raised $25 million and explicitly names Brian Armstrong among the angels.
- Preventive: A biotechnology investment dated 2025.
- Brain Co: A business and productivity software investment dated 2025.
- Orchid Health: A healthcare technology investment dated 2023.
- Nomba: A financial software investment dated 2021.
- Gameto: A biotechnology investment dated 2021.
- Binti: A business and productivity software company with investment entries dated 2019 and 2021.
- Ampleforth: A financial software investment dated 2019.
The list shows disclosed activity across software, fintech, healthcare, and biotechnology. It does not reveal Armstrong's check size, ownership, investment rationale, current stake, or outcome for any company.
PitchBook's exit field names Autonomous Partners, WOMeN.COM, HandUp, Openvote, and Relativity Space. It labels Autonomous Partners as a secondary transaction and Openvote as out of business. That is a useful warning: an “exit” field describes a database status change, not proof that an angel earned a positive return.
What did Brian Armstrong invest in early?
Among the personal investment rows visible in PitchBook's free preview, the earliest are Binti and Ampleforth in 2019. That makes them useful early examples, though it does not prove they were Armstrong's first angel checks. The preview exposes only part of the database, and an undisclosed or unlisted deal could predate them.
Coinbase does not belong in this personal angel list. Armstrong co-founded the company, and Y Combinator invested in Coinbase. Calling that financing the start of “Brian Armstrong investments” reverses who invested in whom.
Companies and projects Brian Armstrong co-founded
Armstrong's official biography identifies a separate set of operating roles. Before Coinbase, he co-founded UniversityTutor, worked as a software engineer at Airbnb, and studied computer science and economics at Rice University. Those experiences are biography, not portfolio holdings.
His disclosed co-founded projects include:
- Coinbase: Armstrong co-founded the cryptocurrency company in 2012 and remains its CEO. His founder equity is economically important, but it is different from an outside angel investment.
- ResearchHub: Armstrong co-founded the open-science platform in 2020. ResearchHub's team page currently names him co-founder and CEO.
- NewLimit: Armstrong co-founded the longevity biotechnology company with Blake Byers and Jacob Kimmel in 2021. In June 2026, NewLimit said it had closed a $435 million Series C to advance epigenetic reprogramming medicines toward human trials. That is financing raised by NewLimit, not evidence of a new personal angel check from Armstrong.
- UniversityTutor: Armstrong co-founded the tutor directory before Coinbase. His bio says it was acquired in 2014.
This distinction matters because a founder can contribute time, intellectual property, initial capital, or all three. A public biography rarely discloses enough detail to convert that relationship into an angel-investment record.
Coinbase Ventures is a corporate portfolio
Coinbase Ventures invests on behalf of Coinbase in companies across the crypto economy. Its official portfolio currently includes Arbitrum, Dune, EigenLayer, Etherscan, Farcaster, Magic Eden, OpenSea, and Optimism, among many others.
Those are Coinbase Ventures portfolio companies. They should not be added to Armstrong's personal angel portfolio unless a separate, reliable record also names him as an individual investor. Armstrong's leadership of Coinbase does not establish that he personally wrote each check, selected each company, or holds a direct personal stake outside his interest in Coinbase.
This is the clean classification:
- Personal angel investments: Deals publicly attributed to Brian Armstrong as an individual, including NavigateAI, Binti, Gameto, and Ampleforth.
- Co-founded operating projects: Companies Armstrong helped create or operate, including Coinbase, ResearchHub, NewLimit, and UniversityTutor.
- Corporate venture investments: Deals made by Coinbase Ventures, including Arbitrum, Dune, OpenSea, and Optimism.
Combining all three buckets produces a much longer list, but a less accurate answer.
What the record suggests about Armstrong's interests
The disclosed personal portfolio is broader than crypto. It includes financial software, enterprise software, AI for skilled trades, healthcare technology, and biotechnology. His operating projects span cryptocurrency infrastructure, scientific research, and longevity medicine. Coinbase Ventures remains focused on crypto and Web3.
That mix supports a modest conclusion: Armstrong participates in several technology categories and repeatedly engages with ambitious technical problems. It does not prove that every investment follows one infrastructure-first thesis. Public records reveal names and rounds more often than selection criteria, portfolio weights, or rejected deals.
The record also cannot support confident claims about returns. A financing announcement or later valuation does not show an individual investor's entry price, dilution, follow-on participation, liquidity, taxes, or realized proceeds. Without those inputs, any return calculation is guesswork.
Practical lessons for angel investors
Armstrong's public record is useful as a research example. It is not a portfolio to copy. Here are four ways to study it without stretching the evidence:
- Identify the investor of record. Ask whether a deal belongs to the person, a company they founded, or a fund affiliated with that company. Similar names do not make the capital source interchangeable.
- Keep dated evidence. Record the announcement, round date, investor name, and source. Our co-founder and general partner Elizabeth Yin writes, “The more disciplined you are in your thought process/rubric, the more you can improve over time.” If two databases disagree, preserve both counts and explain the limit instead of choosing the larger one.
- Separate interest from allocation. A founder may speak often about a sector while committing little personal capital to it, or invest quietly in sectors they rarely discuss. A disclosed list shows participation, not portfolio weight.
- Avoid reverse-engineering returns. Private marks and headline valuations leave out ownership and cash flows. Treat unknown outcomes as unknown.
In Democratizing Knowledge, our co-founder Elizabeth Yin offers a blunt portfolio reminder: “Don't try to pick a co. Select a portfolio.” A public portfolio can generate questions for your own scorecard, but it cannot tell you whether a deal fits your access, expertise, risk tolerance, or opportunity set. Our angel portfolio management guide explains how to track positions and decisions without letting one recognizable name dominate the process.
Private startup investments are speculative, illiquid, and long-term. Any single company can fail and an investor can lose the entire check. If you want to build your judgment with peers and review curated early-stage opportunities, apply to Angel Squad.





.png)